title: Addition of an immunomodulator as a rescue therapy for loss of response to adalimumab dose escalation in patients with Crohn's disease.
authors: Department of Gastroenterology, Evaggelismos Hospital, Athens, Greece.
authors: Konstantinos
authors: K
authors: Papamichael
authors: Department of Gastroenterology, Evaggelismos Hospital, Athens, Greece.
authors: Pantelis
authors: P
authors: Karatzas
authors: Department of Gastroenterology, Evaggelismos Hospital, Athens, Greece gjmantzaris@gmail.com.
authors: Gerassimos J
authors: GJ
authors: Mantzaris
mesh_terms: D000068879:Adalimumab / Q000008:administration & dosage*; D000293:Adolescent; D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage*; D001379:Azathioprine / Q000627:therapeutic use; D003424:Crohn Disease / Q000188:drug therapy* / Q000473:pathology; D004359:Drug Therapy, Combination / Q000009:adverse effects; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D012189:Retrospective Studies; D016879:Salvage Therapy / Q000379:methods*; D055815:Young Adult
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D007166:Immunosuppressive Agents; D000068879:Adalimumab; D001379:Azathioprine; D008727:Methotrexate